Harmony Biosciences Holdings, Inc. HRMY Adjustment For Amortization Of Debt Issuance Costs
Adjustment For Amortization Of Debt Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept hrmy:AdjustmentForAmortizationOfDebtIssuanceCosts.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s adjustment for amortization of debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s adjustment for amortization of debt issuance costs?
- Harmony Biosciences Holdings, Inc. (HRMY) reported adjustment for amortization of debt issuance costs of $151K in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s adjustment for amortization of debt issuance costs changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s adjustment for amortization of debt issuance costs decreased by 9.0% year-over-year, from $166K to $151K.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s adjustment for amortization of debt issuance costs?
- Over 3 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s adjustment for amortization of debt issuance costs has grown at a -33.9% compound annual growth rate (CAGR), from $2.24M to $647K.
- What does adjustment for amortization of debt issuance costs mean?
- This is the non-cash amortization of fees and expenses incurred when securing debt financing, spread over the life of the debt instrument. It is added back to net income in the cash flow statement to reflect that these costs were paid upfront and are not current cash outflows. It provides clarity on the true interest-related cash burden of the company's capital structure.